Since both FLT3-ITD and NPM1 mutations occur in AML cells arrested in different maturation stadia, we evaluated whether differential splicing and differential expression signatures in relation to FLT3-ITD and NPM1 mutations in AML showed FAB subtype specificity. The gene discussed is NPM1; the disease is acute myeloid leukemia.